[Nitric oxide in rheumatoid arthritis].
Migita
Kiyoshi
K
Department of Immunology, Clinical Research Center, NHO Nagasaki Medical Center.
D001172:Arthritis, Rheumatoid / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology; D051546:Cyclooxygenase 2; D015232:Dinoprostone / Q000096:biosynthesis; D015971:Gene Expression Regulation, Enzymologic; D006801:Humans; D020778:Matrix Metalloproteinase 2 / Q000096:biosynthesis / Q000235:genetics; D008565:Membrane Proteins; D009569:Nitric Oxide / Q000096:biosynthesis / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000378:metabolism; D052247:Nitric Oxide Synthase Type II; D030421:Peroxynitrous Acid / Q000096:biosynthesis / Q000502:physiology; D011451:Prostaglandin-Endoperoxide Synthases / Q000096:biosynthesis / Q000235:genetics; D013583:Synovial Membrane / Q000166:cytology / Q000378:metabolism
D008565:Membrane Proteins; D030421:Peroxynitrous Acid; D009569:Nitric Oxide; C496319:NOS2 protein, human; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases; D020778:Matrix Metalloproteinase 2; D015232:Dinoprostone